Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors
暂无分享，去创建一个
L. Coussens | H. Rugo | N. Sharma | A. Dowlati | B. West | A. Marimuthu | A. Peck | R. Wesolowski | P. Severson | B. West | L. Reebel | M. B. Rodal | D. Karlin | M. Le | Neelesh Sharma | Alexandra Peck | David A. Karlin | Mai H. Le